Looks like those who dared to question the science of vaccines have finally been vindicated.
According to a recent study from Yale News, Ivy League researchers have discovered a new syndrome that may be afflicting many different individuals who received the COVID vaccine: post vaccine syndrome.
A rather serious concern, especially for anyone who has had the COVID vaccine coupled with long term concerns.
“COVID-19 vaccines have been instrumental in reducing the impact of the pandemic, preventing severe illness and death, and they appear to protect against long COVID,” Yale News began.
Right. Though there’s a catch …
“However, some individuals have reported chronic symptoms that developed soon after receiving a COVID-19 vaccine. This little-understood, persistent condition, referred to as post-vaccination syndrome (PVS), remains unrecognized by medical authorities, and little is known about its biological underpinnings,” Yale Newscontinued.
Interesting that medical authorities have apparently chosen to not recognize a study from Yale University.
After all, Yale University is one of the most prominent research institutions in the world, not to mention the alma mater of several individuals who have long been buried deep within the swamp and its political machinations.
Moreover, if scientific researchers at Yale are not “medical authorities” or experts, then who is? Fauci?
The study proceeds to detail various symptoms that individuals may experience from PVS, which individuals struggling with longer term healthcare challenges since the pandemic should be well aware of, for their own sake.
“Some of the most common chronic symptoms of PVS include exercise intolerance, excessive fatigue, brain fog, insomnia, and dizziness. They develop shortly after vaccination, within a day or two, can become more severe in the days that follow, and persist over time,” Yale News mused.
Well. What a lovely array of symptoms.
Sounds like the vaccine should have been vetted a bit more prior to being steamrolled into the marketplace. Especially when considering the profound variations that can emerge on an individual level.
Indeed, the researchers examined immune features that differences between the two groups, finding “several differences in immune cell populations.”
Specifically, “those with [post vaccine syndrome] had lower levels of effector CD4+ T cells and higher levels of TNF-alpha+ CD8 T cells … among other differences,” per Yale News.
Both types of cells –effector CD4+ T cells and TNF-alpha+ CD8 T cells – are also white blood cells.
“Typically spike protein can be detected for a few days after vaccination, but some participants with PVS had detectable levels more than 700 days after their last vaccination. Persistent spike protein has been associated with long COVID as well,” Yale News added.
Well, more great news all around. Even more disturbing that “medical authorities” are apparently refusing to discuss this newly discovered PVS, for whatever reason.
Akiko Iwasaki, who works as a Sterling Professor of Immunobiology at Yale School of Medicine (YSM) and served as a co-senior author of the study, found the elevated protein spikes, especially 700+ days after the last vaccination, “surprising.”
A rather mild assessment, to be sure.
“That was surprising, to find spike protein in circulation at such a late time point. We don’t know if the level of spike protein is causing the chronic symptoms, because there were other participants with PVS who didn’t have any measurable spike protein. But it could be one mechanism underlying this syndrome,” Iwasaki mused.
Without a doubt. A mechanism that will also likely be discovered, in due time.
“This work is still in its early stages, and we need to validate these findings. But this is giving us some hope that there may be something that we can use for diagnosis and treatment of PVS down the road,” Iwasaki added.
One can only hope … especially if there really are far more people vulnerable to PVS than realized.
Author: Ofelia Thornton
